SEC Form 4 · accession 0001144204-16-092284
Accelerate Diagnostics, Inc · AXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Mark C Miller
Director
Period of report
Apr 1, 2016
Accepted (ET)
Apr 1, 2016 · 3:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727207
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $8,181.00 | Apr 1, 2016 | A | 8,181 | A | — | Apr 1, 2016 | Common Stock | 8,181 | 114,624 | D |
| Stock Option (right to buy)F1 | $13.30 | holding | — | — | — | — | Nov 5, 2023 | Common Stock | 69,671 | 69,671 | D |
| Stock Option (right to buy) | $13.30 | holding | — | — | — | Nov 4, 2014 | Nov 5, 2023 | Common Stock | 23,224 | 92,895 | D |
| Stock Option (right to buy) | $21.31 | holding | — | — | — | Apr 3, 2015 | Apr 3, 2024 | Common Stock | 5,890 | 98,785 | D |
| Stock Option (right to buy)F2 | $22.92 | holding | — | — | — | — | Apr 2, 2025 | Common Stock | 7,658 | 106,443 | D |
Explanation of responses
- F1The stock option vests in five equal annual installments, with the first installment vesting on November 5, 2014.
- F2The stock option vests in 12 equal monthly installments, with the first installment vesting on May 2, 2015.
- F3The stock option vests in 12 equal monthly installments, with the first installment vesting on May 1, 2016.